These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1311577)

  • 1. Receptor-mediated mechanisms of peroxisome proliferators.
    Green S
    Biochem Pharmacol; 1992 Feb; 43(3):393-401. PubMed ID: 1311577
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypolipidemic effect of peroxisome proliferators. Transcriptional suppression of apolipoprotein C-III.
    Hertz R; Bishara-Shieban J; Bar-Tana J
    Ann N Y Acad Sci; 1996 Dec; 804():731-3. PubMed ID: 8993607
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of rats with the peroxisome proliferator ciprofibrate results in increased liver NF-kappaB activity.
    Li Y; Leung LK; Glauert HP; Spear BT
    Carcinogenesis; 1996 Nov; 17(11):2305-9. PubMed ID: 8968042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxisome proliferators and signal transduction.
    Bronfman M; Nuñez L; Orellana A; Burzio V; Hidalgo P
    Ann N Y Acad Sci; 1996 Dec; 804():403-12. PubMed ID: 8993559
    [No Abstract]   [Full Text] [Related]  

  • 5. Molecular basis of non-responsiveness to peroxisome proliferators: the guinea-pig PPARalpha is functional and mediates peroxisome proliferator-induced hypolipidaemia.
    Bell AR; Savory R; Horley NJ; Choudhury AI; Dickins M; Gray TJ; Salter AM; Bell DR
    Biochem J; 1998 Jun; 332 ( Pt 3)(Pt 3):689-93. PubMed ID: 9620871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of hypolipidemic peroxisome proliferators on the induction of sister chromatid exchanges.
    Linnainmaa K
    Basic Life Sci; 1984; 29 Pt B():965-74. PubMed ID: 6397193
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatic peroxisome proliferation: induction by two novel compounds structurally unrelated to clofibrate.
    Reddy JK; Krishnakantha TP
    Science; 1975 Nov; 190(4216):787-9. PubMed ID: 1198095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peroxisome proliferators: paradigms and prospects.
    Gibson GG
    Toxicol Lett; 1993 May; 68(1-2):193-201. PubMed ID: 8390728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potent peroxisome proliferators inhibit beta-oxidation in the isolated perfused rat liver.
    Bojes HK; Thurman RG
    Toxicol Appl Pharmacol; 1996 Oct; 140(2):322-7. PubMed ID: 8887448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pretreatment with peroxisome proliferators protects mice against some but not all hepatotoxins.
    Nicholls-Grzemski FA; Burcham PC; Calder IC; Priestly BG
    Ann N Y Acad Sci; 1996 Dec; 804():742-4. PubMed ID: 8993611
    [No Abstract]   [Full Text] [Related]  

  • 11. Peroxisome proliferators induce high levels of DNA synthesis in primary cultures of rat hepatocytes.
    Bell DR; Plant NJ; Horley NJ; Elcombe CR
    Ann N Y Acad Sci; 1996 Dec; 804():745-6. PubMed ID: 8993612
    [No Abstract]   [Full Text] [Related]  

  • 12. Role of eicosanoid metabolism in carcinogenesis by peroxisome proliferators.
    Glauert HP; Hong JT; Leung LK; Wilson MW
    Ann N Y Acad Sci; 1996 Dec; 804():719-21. PubMed ID: 8993604
    [No Abstract]   [Full Text] [Related]  

  • 13. Regulation of gene expression by fatty acids and fibric acid derivatives: an integrative role for peroxisome proliferator activated receptors. The Belgian Endocrine Society Lecture 1992.
    Auwerx J
    Horm Res; 1992; 38(5-6):269-77. PubMed ID: 1339170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conjugated linoleic acid activates peroxisome proliferator-activated receptor alpha and beta subtypes but does not induce hepatic peroxisome proliferation in Sprague-Dawley rats.
    Moya-Camarena SY; Van den Heuvel JP; Belury MA
    Biochim Biophys Acta; 1999 Jan; 1436(3):331-42. PubMed ID: 9989264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of peroxisome proliferators on intrachromosomal and interchromosomal recombination in yeast.
    Schiestl RH; Reddy JK
    Carcinogenesis; 1990 Jan; 11(1):173-6. PubMed ID: 2403857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxisome proliferators: species differences in response of primary hepatocyte cultures.
    Elcombe CR; Bell DR; Elias E; Hasmall SC; Plant NJ
    Ann N Y Acad Sci; 1996 Dec; 804():628-35. PubMed ID: 8993577
    [No Abstract]   [Full Text] [Related]  

  • 17. Protein phosphorylation by peroxisome proliferators: species-specific stimulation of protein kinases and its role in PP-induced transcriptional activation.
    Motojima K; Passilly P; Jannin B; Latruffe N
    Ann N Y Acad Sci; 1996 Dec; 804():413-23. PubMed ID: 8993560
    [No Abstract]   [Full Text] [Related]  

  • 18. Hepatocarcinogenesis of peroxisome proliferators.
    Rao MS; Reddy JK
    Ann N Y Acad Sci; 1996 Dec; 804():573-87. PubMed ID: 8993574
    [No Abstract]   [Full Text] [Related]  

  • 19. Hypolipidaemic hepatic peroxisome proliferators form a novel class of chemical carcinogens.
    Reddy JK; Azarnoff DL; Hignite CE
    Nature; 1980 Jan; 283(5745):397-8. PubMed ID: 6766207
    [No Abstract]   [Full Text] [Related]  

  • 20. Structural diversity of peroxisome proliferators and their effects on mammalian liver cells in vivo.
    de la Iglesia F; McGuire EJ; Haskins JR; Lalwani ND
    Ann N Y Acad Sci; 1996 Dec; 804():310-27. PubMed ID: 8993553
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.